DOI QR코드

DOI QR Code

Screening of Inhibitors of Extracellular Serine Protease of Acanthamoeba castellanii from Mushroom Extracts

버섯 추출물로부터 Acanthamoeba castellanii의 세포외 Serine 단백질분해효소 저해제 탐색

  • 이승은 (공주대학교 자연과학대학) ;
  • ;
  • ;
  • 최미영 (선문대학교 건강과학대학) ;
  • 서승염 (공주대학교 자연과학대학)
  • Published : 2008.12.31

Abstract

Although the number of patients with Acanthamoeba keratitis has increased dramatically since the widespread use of contact lens, it is still very hard to cure the disease. The proteases from the Acanthamoeba were reported to play important role in the pathogenesis of keratitis. In this study, the inhibitors for extracellular serine proteases of A. castellanii were screened from the extracts of 230 mushroom samples collected from various regions of Korea. The mushrooms were extracted with methanol and water ($65^{\circ}C$). Filtered and concentrated extracts (0.3 mg/ml) were preincubated with proteases before addition of peptide substrate N-succinyl-ala-ala-pro-phe p-anilide. The selected extracts showing strong inhibitory effects were characterized. Although inhibition with single extract was not so high enough, the complete inhibition was achieved with combination of two extracts. The selected extract showed little effect on other serine proteases such as thrombin (human and bovine) and on general protease such as protease K.

콘텍트렌즈의 착용이 증가하면서 알칸사아메바에 의한 각막염이 급증하지만 아직도 이병을 치료하기가 매우 어려운 실정이다. 이 아메바에서 나오는 serine 단백질분해효소는 각막염의 유발에 중요한 역할을 하고 있다고 알려졌다. 본 연구에서는 A. castellanii의 세포외 serine 단백질분해효소의 활성을 저해하는 능력이 우수한 추출물을 230종 버섯의 메탄올 추출물로부터 선별하였다. 버섯을 메탄올과 물($65^{\circ}C$)로 추출한 후 여과.농축하여 이 추출물을 0.3 mg/ml의 농도로 효소와 반응시킨 후 기질 N-succinylala-ala-pro-phe p-anilide을 넣고 효소의 활성을 측정하여 우수한 저해능을 가진 추출물을 선별하였다. 이렇게 선별된 추출물을 가지고 성질을 연구하였는데, 한 추출물로 활성이 완전하게 억제되지 않았으나 두 추출물을 조합하여 사용하면 활성을 완전하게 억제할 수 있었다. 이 추출물은 다른 serine 단백질분해효소인 인간과 소의 트롬빈과 일반적인 단백질분해효소인 Protease K에는 영향을 미치지 않았다.

Keywords

References

  1. Beattie, A. M., Slomvic, A. R., Rootman, D. S. and Hunter, W. S. 1990. Acanthamoeba keratitis with two species of Acanthamoeba. Can. J. Ophthalmol. 25:260-262
  2. Cao, Z., Jefferson, D. M. and Panjwani, N. 1998. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. J. Biol. Chem. 273:15838-15845 https://doi.org/10.1074/jbc.273.25.15838
  3. Cho, J. H., Na, B. K., Kim, T. S. and Song, C. Y. 2000. Purification and characterization of an extracellular serine protease from Acanthamoeba castellanii. IUBMB Life 50:209-214 https://doi.org/10.1080/152165400300001534
  4. Chu, D. M., Miles, H., Toney, D., Ngyuen, C. and Marciano-Cabral, F. 1998. Amebicidal activity of plant extracts from Southeast Asia on Acanthamoeba spp. Parasitol. Res. 84:746-752 https://doi.org/10.1007/s004360050480
  5. Davis, R. M., Schroeder, R. P., Rowsey, J. J., Jensen, H. G. and Tripathi, R. C. 1987. Acanthamoeba keratitis and infectious crystalline keratopathy. Arch. Ophthalmol. 105:1524-1527 https://doi.org/10.1001/archopht.1987.01060110070034
  6. Fini, M. E, Cook, J. R. and Mohan, R. 1998. Proteolytic mechanism in corneal ulceration and repair. Arch. Dermatol. Res. 290 Suppl:S12-23 https://doi.org/10.1007/PL00007449
  7. Gatti, S., Cevini, C. Bruno, A., Penso, G., Rama, P. and Scaglia, M. 1998. In vitro effectiveness of povidone-iodone on Acanthamoeba isolates from cornea. Antimicrob. Agent Chemother. 42:2232-2234
  8. He, Y. G., Niederkorn, J. Y., McCulley, J. P., Stewart, G. L., Meyer, D. R., Silvany, R. and Dogherty, J. 1990. In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. Invest. Ophthamol. Vis. Sci. 31:2235-2240
  9. Illingworth, C. D. and Cook, S. D. 1998. Acanthamoeba keratitis. Surv. Ophthalmol. 42:493-508 https://doi.org/10.1016/S0039-6257(98)00004-6
  10. Ishibashi, Y. 1997. Acanthamoeba keratitis. Ophtalmologica 211 Suppl 1:39-44 https://doi.org/10.1159/000310885
  11. Jaison, P. L., Cao, Z. and Panjwani, N. 1988. Binding of Acanthamoeba to mannose-glycoproteins of corneal epithelium: effect of injury. Curr. Eye Res. 17:770-776 https://doi.org/10.1080/02713689808951256
  12. Khan, N. A., Jarroll, E. L., Panjwani, N., Cao, Z. and Paget, T. A. 2000. Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. J. Clin. Microbiol. 38:2858-2861
  13. Kilvington, S. and Larkin, D. F. 1990. Acanthamoeba adherence to contact lenses and removal by cleaning agents. Eye 4:589-593 https://doi.org/10.1038/eye.1990.82
  14. Larkin, D. F. and Easty, D. L. Experimental Acanthamoeba keratitis. 1990. I. Preliminary findings. Br. J. Ophthalmol. 74:551-555 https://doi.org/10.1136/bjo.74.9.551
  15. Leher, H., Silvany, R. Alizadeh, H., Huang, J. and Niederkorn, J. Y. 1998. Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect. Immun. 66:5-10
  16. Lehmannn, O. J., Green, S. M., Morlet, N., Kilvington, S., Keys, M. F., Matheson, Dart, J. K., McGill, J. I. and Watt, P. J. 1998. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 39:1261-1265
  17. Lindquist, T. D. 1998. Treatment of Acanthamoeba keratitis. Cornea. 17:11-6 https://doi.org/10.1097/00003226-199801000-00002
  18. Logar, J. and Kraut, A. 1997. Acanthamoeba corneal infection in a contact lens wearer. J. Infect. 35:237-240 https://doi.org/10.1016/S0163-4453(97)92852-8
  19. Mattana, A., Bennatdini, F., Usai, S., Franconi, F. and Cappuccinelli, P. 1997. Acanthamoeba castellanii metabolites increase the intracellular calcium level and cause cytoxicity in wish cells. Microb. Pathol. 23:85-93 https://doi.org/10.1006/mpat.1997.0138
  20. McCulley, J. P., Alizadeh, H. and Niederkorn, J. Y. 1995. Acanthamoeba keratitis. CLAO J. 21:73-76
  21. Morton, L. D., McLaughlin, G. L. and Whiteley, H. E. 1991. Effects of temperature, amebic strain, and carbohydrates on Acanthamoeba adherence to corneal epithelium in vitro. Infect. Immun. 59:3819-3822
  22. Murdoch, D., Gray, T. B., Cursons, R. and Parr, D. 1998. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide. Aust. J Ophthalmol. 26:231-236 https://doi.org/10.1111/j.1442-9071.1998.tb01317.x
  23. Niederkorn, J. Y., Ubelaker, J. E., McCully, J. P., Stewart, G. L., Meyer, D. R., Mellon, J. A., Silvany, R. E., He, Y. G., Pidherney, M. and Martin, J. H. 1992. Susceptibility of corneal from various animal species to in vitro binding and invasion by Acanthamoeba castellanii. Invest. Ophthamol. Vis. Sci. 33:104-112
  24. Reimerdes, E. and Klostermeyer, H. 1976. Determination of proteolytic activity on casein substrates. Methods in Enzymolgy 45:26-28 https://doi.org/10.1016/S0076-6879(76)45005-X
  25. Rottenberg, R., Christensen, U. Jackson, C. and Coleman, P. 1981. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods in Enzymolgy 80:341-361 https://doi.org/10.1016/S0076-6879(81)80030-4
  26. Schaumberg, D. A., Snow, K. K. and Dana, M. R. 1998. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3-10 https://doi.org/10.1097/00003226-199801000-00001
  27. Tahara, K., Asari, S., Shimomura, Y., Endo, T. and Yanagihara, T. 1997. Evaluation of effective treatment drugs against Acanthamoeba cyst. Kansenshogaku Zasshi 71:1025-1030
  28. van Klink, F., Alizadeh, H., Stewart, G. L., Pidherney, M. S., Silvany R. E., He, Y., McCulley, J. P. and Niederkorn, J. Y. 1992. Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr. Eye Res. 11:1207-1220 https://doi.org/10.3109/02713689208999546
  29. Wang, I. J., Hong, J. P. and Hu, F. R. 1997. Clinical features and outcome of Acanthamoeba keratitis. J. Formos. Med. Assoc. 96:895-900
  30. Yang, Z., Cao, Z. and Panjwani, N. 1997. Pathogenesis of Acanthamoeba keratitis: carbohydrate-mediated host-parasite interactions. Infect. Immun. 65:439-445